A review of Cushing's disease treatment by the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism

Bibliographic Details
Title: A review of Cushing's disease treatment by the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism
Authors: Machado, Márcio Carlos, Fragoso, Maria Candida Barisson Vilares, Moreira, Ayrton Custódio, Boguszewski, César Luiz, Vieira Neto, Leonardo, Naves, Luciana A., Vilar, Lucio, Araújo, Luiz Antônio de, Musolino, Nina Rosa Castro, Miranda, Paulo Augusto C., Czepielewski, Mauro A., Gadelha, Monica R., Bronstein, Marcello Delano, Ribeiro-Oliveira Jr., Antônio
Source: Archives of Endocrinology and Metabolism. February 2018 62(1)
Publisher Information: Sociedade Brasileira de Endocrinologia e Metabologia, 2018.
Publication Year: 2018
Subject Terms: Cushing's disease, Cushing's syndrome, treatment
More Details: The treatment objectives for a patient with Cushing's disease (CD) are remission of hypercortisolism, adequate management of co-morbidities, restoration of the hypothalamic-pituitary-adrenal axis, preservation of fertility and pituitary function, and improvement of visual defects in cases of macroadenomas with suprasellar extension. Transsphenoidal pituitary surgery is the main treatment option for the majority of cases, even in macroadenomas with low probability of remission. In cases of surgical failure, another subsequent pituitary surgery might be indicated in cases with persistent tumor imaging at post surgical magnetic resonance imaging (MRI) and/or pathology analysis of adrenocorticotropic hormone-positive (ACTH+) positive pituitary adenoma in the first procedure. Medical treatment, radiotherapy and adrenalectomy are the other options when transsphenoidal pituitary surgery fails. There are several options of medical treatment, although cabergoline and ketoconazole are the most commonly used alone or in combination. Novel treatments are also addressed in this review. Different therapeutic approaches are frequently needed on an individual basis, both before and, particularly, after surgery, and they should be individualized. The objective of the present review is to provide the necessary information to achieve a more effective treatment for CD. It is recommended that patients with CD be followed at tertiary care centers with experience in treating this condition.
Document Type: article
File Description: text/html
Language: English
ISSN: 2359-3997
DOI: 10.20945/2359-3997000000014
Access URL: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972018000100087
Rights: info:eu-repo/semantics/openAccess
Accession Number: edssci.S2359.39972018000100087
Database: SciELO
More Details
ISSN:23593997
DOI:10.20945/2359-3997000000014
Published in:Archives of Endocrinology and Metabolism
Language:English